Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baiyu Ginkgolide injection safety study in ischemic stroke with blood stasis syndrome
ChiCTR-ONC-13003247Phase 4Completed
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Ginkgo diterpene lactone meglumine in ischemic stroke, sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Adverse events, Vital signs and 5 more. Started Jun 2013; status: completed.
02
Drugs
Ginkgo diterpene lactone meglumine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-ONC-13003247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-13003247.